Molbio Diagnostics IPO GMP Today
The Molbio Diagnostics IPO GMP is ₹126 (+15.6% over the upper price band of ₹807) as of 15 Aug 2026, giving an estimated listing price of ₹933 per share. On a minimum application of 18 shares, that is an estimated gain of ₹2,268. GMP has fallen by ₹94 since tracking began on 6 Aug.
Last updated
- Issue Price
- ₹807
- GMP
- ₹126
- GMP %
- +15.6%
- Est. listing
- ₹933
- Est. gain / application
- +₹2,268
Molbio Diagnostics IPO GMP trend
Tracked for 12 days. High ₹220 on 6 Aug, low ₹0 on 4 Aug.
Molbio Diagnostics IPO GMP day-wise
| Date | GMP | Change | GMP % | Est. listing | Est. gain (18 sh) |
|---|---|---|---|---|---|
| (latest) | ₹126 | +₹11 | 15.61% | ₹933 | +₹2,268 |
| ₹115 | -₹41 | 14.25% | ₹922 | +₹2,070 | |
| ₹156 | +₹2 | 19.33% | ₹963 | +₹2,808 | |
| ₹154 | +₹16 | 19.08% | ₹961 | +₹2,772 | |
| ₹138 | +₹11 | 17.10% | ₹945 | +₹2,484 | |
| ₹127 | -₹5 | 15.74% | ₹934 | +₹2,286 | |
| ₹132 | +₹2 | 16.36% | ₹939 | +₹2,376 | |
| ₹130 | -₹50 | 16.11% | ₹937 | +₹2,340 | |
| ₹180 | +₹180 | 22.30% | ₹987 | +₹3,240 | |
| ₹0 | -₹170 | 0.00% | ₹807 | ₹0 | |
| ₹170 | -₹50 | 21.07% | ₹977 | +₹3,060 | |
| ₹220 | — | 27.26% | ₹1,027 | +₹3,960 |
Est. listing = upper price band (₹807) + GMP. Est. gain = GMP × 18 shares (1 lot, the minimum application).
Molbio Diagnostics IPO subscription status
| QIB | 186.39x |
|---|---|
| bNII | 50.82x |
| sNII | 47.76x |
| Retail | 12.96x |
| Total | 70.26x |
Reading the Molbio Diagnostics IPO GMP
The grey market premium is the price above the issue price at which Molbio Diagnostics IPO shares are informally traded before listing. A GMP of ₹126 on an upper band of ₹807 suggests the shares could open around ₹933, if grey market sentiment holds until listing day.
GMP is not set by the company, the exchanges or SEBI. It moves daily with market conditions and subscription demand. Check it together with the subscription numbers and the company's financials before applying.
Molbio Diagnostics IPO GMP: FAQs
- What is Molbio Diagnostics IPO GMP today?
- The latest grey market premium (GMP) for the Molbio Diagnostics IPO is ₹126 as of 15 August 2026, which is 15.61% over the upper price band of ₹807.
- What is the expected listing price of Molbio Diagnostics IPO?
- Based on the current GMP, the estimated listing price of Molbio Diagnostics IPO is ₹933 per share (₹807 issue price + ₹126 GMP). This is an estimate from unofficial grey market trades, not a guaranteed listing price.
- What is the lot size and minimum investment for Molbio Diagnostics IPO?
- The lot size is 18 shares. The minimum application is 1 lot, which costs ₹14,526 at the upper price band.
- Is IPO GMP reliable?
- GMP reflects unofficial trades before listing and changes daily with market mood and subscription demand. It is a useful sentiment indicator but often differs from the actual listing price, so use it alongside the company's financials and subscription data.
GMP is an unofficial indicator compiled from grey market sources and is not investment advice. Actual listing prices can differ significantly. Read the offer document before investing.